The American Psychiatric Foundation has announced the launch of a national collaborative initiative to move people from jails into psychiatric care. The Foundation is the philanthropic and educational arm of the American Psychiatric Association. It’s “Corporate Advisory Council” and major contributors are all pharmaceutical companies.
“The American Psychiatric Foundation today joins other leading organizations in supporting the Stepping Up Initiative, an unprecedented national collaboration designed to generate action in communities across the country for a common goal: to reduce the number of people with mental illnesses in U.S. jails,” stated a press release from the American Psychiatric Association. “Stepping Up is being led by the National Association of Counties (NACo), the Council of State Governments (CSG) Justice Center and the American Psychiatric Foundation (APF), with support from the U.S. Department of Justice’s Bureau of Justice Assistance (BJA).”
The APF website identifies its “Foundation Patrons” as Alkermes and Janssen Pharmaceuticals. “Sustaining Members” include Eli Lilly, Lundbeck and Otsuka. “Sponsors” include Genomind, Shire, Sunovion, and
Takeda. All of its listed “Donors” are also pharmaceutical companies.
Reducing the number of people with mental illnesses in US jails (American Psychiatric Association press release on MedicalXpress, May 6, 2015)